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INTRODUCTION
Serum low-density lipoprotein cholesterol (LDL-C) is a well-
known risk factor for cardiovascular (CV) diseases (coronary 
artery disease and peripheral arterial diseases) [1, 2]. The 
prevalence of dyslipidaemia in Poland continues to be high. 
The highest incidence of increased serum LDL-C levels was 
found in persons between 40 and 59 years old, similarly as 
in the case of increased serum total cholesterol [3]. 
Atherosclerosis is a chronic inflammatory process, initi-
ated by damage to the vascular endothelium, which leads to 
remodelling of the artery wall. Serum LDL-C plays a signifi-
cant role in this pathology because oxidised LDL molecules 
activate a number of cellular responses in macrophages, 
endothelial cells, T-cells, and smooth muscle cells, which 
promotes inflammation and atherogenesis [4–6]. The initial 
phase of atherosclerosis involves arterial wall remodelling and 
a subsequent decrease of its compliance (or increased stiff-
ness). Arterial stiffness is an early marker of arteriosclerosis and 
an established predictor of CV morbidity and mortality [7, 8]. 
Assessment of the elastic properties of the arterial wall is a sig-
nificant diagnostic tool that enables early detection of the vas-
cular pathology, before the clinical symptoms appear [9–11]. 
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A b s t r a c t
Background: Elevated serum low-density lipoprotein cholesterol (LDL-C) concentration is a risk factor for atherosclerosis, 
which involves remodelling of the arterial walls with their subsequent stiffening.
Aim: We sought to evaluate the relationship between serum lipid levels and the elastic properties of the arterial wall.
Methods: The study group comprised 315 men and women aged 55.84 ± 9.44 years. Serum glucose and lipid concentrations 
were determited. All subjects underwent blood pressure (BP) measurement, transthoracic echocardiography, and assessment 
of vascular compliance of large (C1) and small arteries (C2) using the HDI/Pulse Wave™ CR-2000 Research CardioVascular 
Profiling System (Hypertension Diagnostics Inc., Eagan, MN, USA). The subjects were divided into three groups: group I  
— LDL-C < 2.6 mmol/L, group II — LDL-C ≥ 2.6 mmol/L and < 4.0 mmol/L, and group III — LDL-C ≥ 4.0 mmol/L.
Results: There were no intergroup differences with regard to smoking status (p = 0.56), serum glucose concentration (p = 0.13), 
body mass index (p = 0.96), systolic (p = 0.17) and diastolic BP (p = 0.29), or C1 (p = 0.09). However, C2 was higher in 
groups I and II than in group III (5.12 ± 2.57 vs. 5.18 ± 2.75 vs. 4.20 ± 1.58 mL/mmHg × 100, respectively, p < 0.01). 
Multivariate regression analysis negated the independent associations between C1 and serum lipid levels. In contrast, C2 was 
independently inversely associated with serum LDL-C concentration (r = –0.15, p < 0.01). 
Conclusions: Higher serum LDL-C concentration seems to contribute independently to stiffening of small arterial vasculature 
in otherwise healthy adults. Screening for dyslipidaemia in the general population and its prompt treatment are highly recom-
mended.
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Diagnosing atherosclerosis at this earliest possible stage can be 
crucial for treatment outcomes. Assessment of the elastic prop-
erties of the arterial wall with a non-invasive technique provides 
information about the functional and structural changes at the 
level of the aorta, muscular conduit arteries, their peripheral 
branches, and the microvascular components [10].
The aim of the study was to evaluate the relationships 
between serum LDL-C concentration and arterial wall elastic-
ity indices reflective of the large and small artery compliances.
METHODS
The study was conducted as a part of the Silesian Cardiovas-
cular Study, which is an investigation designed to examine the 
risk factors underlying CV disorders and which was approved 
by the Bioethical Committee of the Medical University of 
Silesia. All subjects (Polish, white) were recruited from the 
general population in three reference centres for CV diseases 
in the south of Poland. 
Serum fasting levels of total cholesterol, high-density lipo-
protein cholesterol (HDL-C), triglycerides, LDL-C, and glucose 
were measured. The compliance of large and small arteries 
was assessed non-invasively and automatically using the 
HDI/Pulse Wave™ CR-2000 Research CardioVascular Profiling 
Instrument System (Hypertension Diagnostics Inc., Eagan, MN, 
USA). Subjects were tested after a five-minute rest, in a re-
cumbent position, with their head raised no higher than 30o. 
Blood pressure (BP) was measured automatically with the 
oscillometric method. Radial artery pulse wave analysis was 
performed on the right limb with the use of a piezoelectric 
sensor (applanation tonometry method). In order to minimise 
artefacts, the wrist was stabilised in supination with a dedi-
cated tool. The principle of the applied method takes into ac-
count BP changes during cardiac diastole and is based on the 
analogy to an electric current circuit according to a modified 
Windkessel model [12]. Two vascular systems are distinguished 
in this model: a high-pressure one, which includes the aorta 
with its main branches, and a low-pressure one, involving 
peripheral arteries. As a result, the following parameters are 
obtained: systolic (SBP) and diastolic BP (DBP), large artery 
elasticity index reflective of large artery compliance (C1, 
expressed in mL/mmHg × 10), and small artery elasticity 
index reflective of small artery compliance (C2, expressed in 
mL/mmHg × 100) [9]. 
Echocardiography was performed in all subjects by the 
same experienced sonographer using a Vivid 4 cardiac sys-
tem equipped with a 3.5-MHz transducer (Med-Electronics, 
Beltsville, MD, USA).
Healthy subjects aged ≥ 18 years, who provided writ-
ten informed consent were included in the study. Exclusion 
criteria comprised presence of any disease or treatment with 
any medication. Subjects whose serum fasting glucose level 
was elevated (≥ 100 mg/dL) in the baseline tests were also 
excluded from the study. 
Statistical analysis 
Statistical analysis was performed using the GraphPad InStat 
software, version 3.05 (GraphPad Software, San Diego, CA, 
USA). The demographic, anthropometric, clinical, as well as 
the analysed haemodynamic and biochemical parameters 
were compared between the groups with Kruskal-Wallis 
analysis of variance and Mann-Whitney test for the post-hoc 
comparisons. Simple correlations between serum total cho-
lesterol, HDL-C, triglycerides, LDL-C, and arterial parameters 
were assessed with Pearson’s correlation test. Backward step-
wise multivariate regression analysis was used to establish the 
independent determinants of C1 and C2. The p-value < 0.05 
was considered statistically significant. 
RESULTS
A total of 315 men and women at the average age of 55.84 ± 
± 9.44 years were included in the study and divided into three 
groups according to their serum LDL-C concentration (group I 
— LDL-C < 2.6 mmol/L, group II — LDL-C ≥ 2.6 mmol/L 
and < 4.0 mmol/L, and group III — LDL-C ≥ 4.0 mmol/L). 
The demographic and clinical characteristics of the study 
participants are reported in Table 1. There were no differences 
between the groups in terms of the body mass index (BMI; 
p = 0.96), serum triglycerides (p = 0.09), glucose (p = 0.13), 
smoking status (p = 0.56), SBP (p = 0.17), and DBP (p = 0.29). 
There was no significant intergroup difference with re-
gard to C1 (14.16 ± 4.52 vs. 15.35 ± 4.84 vs. 15.83 ± 
± 6.29 mL/mmHg × 10, p = 0.09), whereas C2 was higher 
in groups I and II than in group III (5.12 ± 2.57 vs. 5.18 ± 
± 2.75 vs. 4.20 ± 1.58 mL/mmHg × 100, p = 0.005; 
Table 1). Moreover, the subjects did not differ in terms of echo-
cardiographic parameters of the left atrium and left ventricle 
(Table 2). The correlation test revealed univariate positive as-
sociations between C1 and serum total cholesterol (r = 0.15, 
p < 0.01), as well as C1 and serum LDL-C (r = 0.12, 
p = 0.03), but no significant correlations between C1 and 
serum HDL-C (p = 0.08) or triglycerides (p = 0.28). In the 
multivariate regression analysis, the correlations of C1 with se-
rum cholesterol concentrations were lost, and only female sex, 
younger age, lower SBP, and higher BMI were independently 
associated with higher large-artery compliance (Table 3). 
On the other hand, inverse univariate correlations were found 
between C2 and serum total cholesterol (r = –0.13, p = 0.02), 
as well as LDL-C (r = –0.15, p < 0.01, Fig. 1). Moreover, lower 
serum LDL-C concentration, along with younger age, female 
sex, and higher BMI correlated independently with higher C2 
in the multivariate regression analysis (Table 3).
DISCUSSION
In this study we aimed to define the relationship between 
serum LDL-C concentration and arterial wall compliance/stiff-
ness. Based on the presented results, we found a negative cor-
relation between serum LDL-C and small-artery compliance. 
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Table 1. Demographic, biochemical, and clinical characteristics of the study group
Group I




(serum LDL-C  
≥ 2.6 and < 4.0 mmol/L)
n = 134
Group III




Male/Female sex 59/24 85/49 63/35 0.48
Age [years] 58.28 ± 10.49 55.01 ± 9.71 54.91 ± 7.71 0.03
BMI [kg/m2] 27.36 ± 3.97 27.39 ± 3.79 27.51 ± 4.13 0.96
Serum total cholesterol [mmol/L] 3.79 ± 0.49 5.09 ± 0.54 6.83 ± 1.02 < 0.0001
Serum HDL-C [mmol/L] 0.87 ± 0.33 1.00 ± 0.32 1.03 ± 0.31 < 0.0001
Serum triglycerides [mmol/L] 1.83 ± 1.02 1.64 ± 0.92 1.81 ± 0.95 0.09
Serum LDL-C [mmol/L] 2.08 ± 0.40 3.35 ± 0.39 4.97 ± 0.84 < 0.0001
Serum glucose [mg/dL] 83.28 ± 11.62 83.36 ± 9.82 85.88 ± 9.94 0.13
Smokers/Non-smokers 52/31 (62.65/37.35) 74/60 (55.22/44.78) 60/38 (61.22/38.78) 0.56
SBP [mmHg] 123.46 ± 13.77 124.49 ± 11.69 121.30 ± 13.37 0.17
DBP [mmHg] 71.89 ± 9.04 72.80 ± 8.78 70.87 ± 9.95 0.29
C1 [mL/mmHg × 10] 14.16 ± 4.52 15.35 ± 4.84 15.83 ± 6.29 0.09
C2 [mL/mmHg × 100] 5.12 ± 2.57 5.18 ± 2.75 4.20 ± 1.58 0.005
Data are presented as mean ± standard deviation or number (percentage). BMI — body mass index; C1 — large-artery elasticity index; C2 — 
small-artery elasticity index; DBP — diastolic blood pressure; HDL-C — high-density lipoprotein cholesterol; LDL-C — low-density lipoprotein 
cholesterol; SBP — systolic blood pressure
Table 2. Echocardiographic parameters of the study group
Group I
(serum LDL-C  
< 2.6 mmol/L)
Group II
(serum LDL-C  
≥ 2.6 and < 4.0 mmol/L)
Group III
(serum LDL-C  
≥ 4.0 mmol/L)
p
LA [mm] 38.85 ± 4.69 38.43 ± 4.04 38.5 ± 3.76 0.75
IVSDD [mm] 11.04 ± 1.76 10.51 ± 1.8 11.05 ± 1.63 0.07
PWDD [mm] 10.68 ± 1.55 10.22 ± 1.43 10.64 ± 1.29 0.04
LVESD [mm] 33.94 ± 8.49 33.39 ± 6.54 34.16 ± 7.48 0.64
LVEDD [mm] 50.55 ± 6.00 50.97 ± 4.96 51.15 ± 5.25 0.18
LVEF [%] 54.87 ± 6.40 56.10 ± 8.92 56.97 ± 7.64 0.14
Data are presented as mean ± standard deviation. IVSDD — intraventricular septum diastolic diameter; LA — left atrium; LVEDD — left ventricular 
end-diastolic diameter; LVEF — left ventricular ejection fraction; LVESD — left ventricular end-systolic diameter; PWDD — posterior wall diastolic 
diameter
Table 3. Multivariate regression analysis with large artery compliance (C1) and small artery compliance (C2) as dependent variables
Dependent variables Independent variables b-coefficient 95% CI p 
C1 Male sex –0.33 –0.29 to –0.37 < 0.01
Age –0.22 –0.18 to 0.26 < 0.01
BMI 0.23 0.19 to 0.27 < 0.01
SBP –0.37 –0.32 to –0.42 < 0.01
C2
Male sex –0.26 –0.21 to –0.31 < 0.01
Age –0.24 –0.19 to –0.29 < 0.01
BMI 0.20 0.15 to 0.25 < 0.01
Serum LDL-C concentration –0.18 –0.13 to –0.23 < 0.01
CI — confidence interval; other abbreviations — see Table 1
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Figure 1. Plot of Pearson’s correlation between small-artery 
elasticity index C2 and serum low-density lipoprotein cholesterol 
(LDL-C)
The results of our research partially coincide with those 
obtained by Schillinger et al. [13], who showed an associa-
tion between high serum concentrations of lipoprotein(a) (a 
modified LDL particle with strong pro-inflammatory and 
pro-atherogenic effects [14]) and reduced compliance of 
the small artery walls. In a group of subjects with athero-
sclerosis, the observed negative correlation between serum 
lipoprotein(a) and C2 was independent of other risk factors 
such as sex, smoking status, and diabetes. Moreover, no 
independent correlation between serum lipoprotein(a) and 
C1 was shown. On the other hand, Miao et al. [15] did not 
reveal any independent relationships between serum total 
cholesterol or LDL-C and the elastic properties of the vascular 
wall. However, they ascertained associations of low serum 
HDL-C or elevated triglycerides with reduced compliance 
of the arterial wall. Moreover, they were able to show a re-
lationship between compliance of the vascular wall and left 
ventricular diastolic function. In our study, in line with that of 
Canepa et al. [16], we did not corroborate any correlations 
between the artery wall elasticity indices and left ventricular 
end-diastolic diameter. This is in contrast to the majority of 
clinical studies that showed an association between reduced 
compliance (or increased stiffness) of the arterial walls and 
left ventricular diastolic dysfunction [17]. With decreasing 
arterial wall compliance, cardiac afterload increases because 
of the accelerated return of the arterial reflection wave from 
the periphery during systole, which augments the SBP and 
results in excess stress to the left ventricle [17]. In our work, 
similarly to Canepa et al. [16], the average age of the studied 
subjects was lower in comparison to other studies, which may 
partially explain the discrepancy between the study findings.
The pathophysiology of arterial stiffening involves extra-
cellular matrix remodelling with fragmentation of elastin and 
deposition of collagen in the arterial walls. Elastin fibres have 
mechanical properties of elasticity, whereas collagen is sig-
nificantly stiffer than elastin [18]. Importantly, elastin contains 
hydrophobic domains, which makes it attractive for interactions 
with ligands such as cholesterol. Bilici et al. [19] revealed det-
rimental modifications of elastin due to cholesterol exposure 
in vitro. It may be assumed that such changes occur in vivo in 
the course of dyslipidaemia and contribute to arterial stiffening. 
Biochemical analyses have revealed that lipids accumulating 
on the membranes of atherosclerotic lesions are bonded with 
elastin already at the early stages of atherosclerosis [19, 20]. 
As mentioned above, non-invasive measurement of vas-
cular wall compliance makes it possible to detect pathologies 
before the clinical symptoms of the CV disease appear. The 
decreased compliance of small artery walls reflects the disturbed 
function of the vascular endothelium and has been established 
as an independent CV risk factor [21, 22]. Panaich et al. [23] 
showed that both small and large artery compliances were as-
sociated with subclinical coronary atherosclerosis in subjects 
free from symptomatic angina. This association was independ-
ent of CV risk factors, i.e. age, sex, race, SBP, diabetes, smoking 
status, serum total cholesterol, HDL-C, and high-sensitivity 
C-reactive protein [23]. In a prospective study, Grey et al. [24] 
demonstrated an association between the increased stiffness of 
the small arteries and occurrence of CV events. Similarly to our 
work, the methodology of the measurement of elasticity indices 
of the small and large arteries was based on the modified Wind-
kessel model. In a long-term observation CV events occurred 
in 41% of the studied subjects, and both C1 and C2 were their 
univariate predictors, whereas only C2 was found to predict CV 
events after taking into account the effect of age [24]. 
In our study we have shown that higher serum LDL-C 
appears to contribute independently to small-artery stiffen-
ing in otherwise heathy adults. A decreased compliance (or 
increased stiffness) of these arteries in subjects without diag-
nosed CV disease can suggest a very early disease course and 
be the indication to extend patient diagnostics. 
Other parameters, such as serum C-reactive protein, ami-
notransferases, uric acid, creatinine, glomerular filtration rate, 
and oxidised LDL, which may influence the elastic properties 
of the arteries, were not taken into consideration in our study.
In conclusion, the small artery compliance is lower among 
subjects with higher serum LDL-C concentration, and there is 
an inverse correlation between these two factors.
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WHAT IS NEW?
Decreased arterial compliance (or increased stiffness) is an early marker of arteriosclerosis and an established predictor 
of cardiovascular morbidity and mortality. Non-invasive assessment of the elastic properties of the arterial wall enables 
early detection of the vascular pathology, before the clinical symptoms appear. Diagnosing atherosclerosis at this earliest 
possible stage can be crucial for treatment outcomes. We demonstrate that higher concentrations of serum low-density 
lipoprotein cholesterol appear to contribute independently to stiffening of the peripheral arterial vasculature in otherwise 
healthy adults. The importance of screening for dyslipidaemia in the general population and its prompt treatment are 
corroborated by the study findings.
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